lexisONE® Community
for Louisiana State Bar Association
Free Case Law Search Results
1. Takeda Chem. Indus. v. Alphapharm Pty., Ltd., 06-1329, UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT, June 28, 2007, Decided
OVERVIEW: The manufacturer of a generic version of pioglitazone, a compound successful in anti-diabetic treatment, failed to show by clear and convincing evidence that the patent for the drug was invalid as obvious under 35 U.S.C.S. § 103, at the time the invention was made. Structurally similar compounds taught away from the invention.
Select a case name link to read the full display of the case — absolutely FREE!
If you are not a registered lexisONE® Community user, you will be asked to register.
Registration is free.
